370 related articles for article (PubMed ID: 15713642)
1. The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification.
Lee MB; Lebedeva LA; Suzawa M; Wadekar SA; Desclozeaux M; Ingraham HA
Mol Cell Biol; 2005 Mar; 25(5):1879-90. PubMed ID: 15713642
[TBL] [Abstract][Full Text] [Related]
2. The DEAD box protein DP103 is a regulator of steroidogenic factor-1.
Ou Q; Mouillet JF; Yan X; Dorn C; Crawford PA; Sadovsky Y
Mol Endocrinol; 2001 Jan; 15(1):69-79. PubMed ID: 11145740
[TBL] [Abstract][Full Text] [Related]
3. A novel domain within the DEAD-box protein DP103 is essential for transcriptional repression and helicase activity.
Yan X; Mouillet JF; Ou Q; Sadovsky Y
Mol Cell Biol; 2003 Jan; 23(1):414-23. PubMed ID: 12482992
[TBL] [Abstract][Full Text] [Related]
4. SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4.
Ihara M; Yamamoto H; Kikuchi A
Mol Cell Biol; 2005 May; 25(9):3506-18. PubMed ID: 15831457
[TBL] [Abstract][Full Text] [Related]
5. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9.
Komatsu T; Mizusaki H; Mukai T; Ogawa H; Baba D; Shirakawa M; Hatakeyama S; Nakayama KI; Yamamoto H; Kikuchi A; Morohashi K
Mol Endocrinol; 2004 Oct; 18(10):2451-62. PubMed ID: 15192080
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification.
Ohshima T; Koga H; Shimotohno K
J Biol Chem; 2004 Jul; 279(28):29551-7. PubMed ID: 15123625
[TBL] [Abstract][Full Text] [Related]
7. Modification of GATA-2 transcriptional activity in endothelial cells by the SUMO E3 ligase PIASy.
Chun TH; Itoh H; Subramanian L; Iñiguez-Lluhí JA; Nakao K
Circ Res; 2003 Jun; 92(11):1201-8. PubMed ID: 12750312
[TBL] [Abstract][Full Text] [Related]
8. SUMOylation of RORalpha potentiates transcriptional activation function.
Hwang EJ; Lee JM; Jeong J; Park JH; Yang Y; Lim JS; Kim JH; Baek SH; Kim KI
Biochem Biophys Res Commun; 2009 Jan; 378(3):513-7. PubMed ID: 19041634
[TBL] [Abstract][Full Text] [Related]
9. PIASy inhibits LRH-1-dependent CYP11A1 expression by competing for SRC-1 binding.
Hsieh HT; Wang CH; Wu ML; Yang FM; Tai YC; Hu MC
Biochem J; 2009 Apr; 419(1):201-9. PubMed ID: 19067654
[TBL] [Abstract][Full Text] [Related]
10. Liver receptor homolog-1 localization in the nuclear body is regulated by sumoylation and cAMP signaling in rat granulosa cells.
Yang FM; Pan CT; Tsai HM; Chiu TW; Wu ML; Hu MC
FEBS J; 2009 Jan; 276(2):425-36. PubMed ID: 19125815
[TBL] [Abstract][Full Text] [Related]
11. SUMO modification negatively modulates the transcriptional activity of CREB-binding protein via the recruitment of Daxx.
Kuo HY; Chang CC; Jeng JC; Hu HM; Lin DY; Maul GG; Kwok RP; Shih HM
Proc Natl Acad Sci U S A; 2005 Nov; 102(47):16973-8. PubMed ID: 16287980
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a strong repression domain in the hinge region of orphan nuclear receptor hB1F/hLRH-1.
Xu PL; Shan SF; Kong YY; Xie YH; Wang Y
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):909-16. PubMed ID: 14515208
[TBL] [Abstract][Full Text] [Related]
13. SUMO modification of the DEAD box protein p68 modulates its transcriptional activity and promotes its interaction with HDAC1.
Jacobs AM; Nicol SM; Hislop RG; Jaffray EG; Hay RT; Fuller-Pace FV
Oncogene; 2007 Aug; 26(40):5866-76. PubMed ID: 17369852
[TBL] [Abstract][Full Text] [Related]
14. Role for SUMO modification in facilitating transcriptional repression by BKLF.
Perdomo J; Verger A; Turner J; Crossley M
Mol Cell Biol; 2005 Feb; 25(4):1549-59. PubMed ID: 15684403
[TBL] [Abstract][Full Text] [Related]
15. Modulation of transcriptional activity of the DEAD-box family of RNA helicases, p68 (Ddx5) and DP103 (Ddx20), by SUMO modification.
Fuller-Pace FV; Jacobs AM; Nicol SM
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1427-9. PubMed ID: 18031238
[TBL] [Abstract][Full Text] [Related]
16. PIASy-mediated repression of the androgen receptor is independent of sumoylation.
Gross M; Yang R; Top I; Gasper C; Shuai K
Oncogene; 2004 Apr; 23(17):3059-66. PubMed ID: 14981544
[TBL] [Abstract][Full Text] [Related]
17. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.
Sentis S; Le Romancer M; Bianchin C; Rostan MC; Corbo L
Mol Endocrinol; 2005 Nov; 19(11):2671-84. PubMed ID: 15961505
[TBL] [Abstract][Full Text] [Related]
18. Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life.
Wong KA; Kim R; Christofk H; Gao J; Lawson G; Wu H
Mol Cell Biol; 2004 Jun; 24(12):5577-86. PubMed ID: 15169916
[TBL] [Abstract][Full Text] [Related]
19. SUMO modification of repression domains modulates function of nuclear receptor 5A1 (steroidogenic factor-1).
Chen WY; Lee WC; Hsu NC; Huang F; Chung BC
J Biol Chem; 2004 Sep; 279(37):38730-5. PubMed ID: 15192092
[TBL] [Abstract][Full Text] [Related]
20. Decreased recognition of SUMO-sensitive target genes following modification of SF-1 (NR5A1).
Campbell LA; Faivre EJ; Show MD; Ingraham JG; Flinders J; Gross JD; Ingraham HA
Mol Cell Biol; 2008 Dec; 28(24):7476-86. PubMed ID: 18838537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
